Thanks Ryann - appreciate the context as I hadn't seen the interview.
On reflection James has a difficult role in that he would obviously be aware of a lot more developments at any one time than what he's able to talk freely about. I know I'd find it difficult to censor myself but I guess it's in the MD's position description to continually disclose without misleading or overstepping.
So far he's doing a great job and I really look forward to the de-risking of this gem of a Company and realising our potential value.
So glad I went early and big for me ( modest by the holdings of a lot of posters though).
James Marsh - MD Interviews, page-131
-
- There are more pages in this discussion • 458 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
-0.001(5.88%) |
Mkt cap ! $27.14M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $10.17K | 1.150M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 49 | 14954233 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 18530586 | 22 |
View Market Depth
| Last trade - 14.32pm 11/10/2024 (20 minute delay) ? |
| ADN (ASX) Chart |